Journal list menu
Export Citations
Download PDFs
Issue Information
Editorials
Open Access
oa
Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST-WHF in perspective
- Pages: 3261-3267
- First Published: 22 December 2020
Open Access
oa
Embracing secondary mitral regurgitation with Carillon: past, present, and future
- Pages: 3268-3270
- First Published: 22 December 2020
Open Access
oa
New treatment options to reduce heart failure hospitalization
- Pages: 3271-3273
- First Published: 03 December 2020
Open Access
oa
The (apparent) sacubitril/valsartan sex interaction in heart failure with preserved ejection fraction: not the result of relaxin effects but of BNP action?!
- Pages: 3274-3277
- First Published: 15 December 2020
Open Access
oa
Transforming heart failure and cardio-oncology care during COVID-19
- Pages: 3278-3280
- First Published: 18 September 2020
Open Access
oa
Secondary mitral regurgitation: reducing the leak, expanding the science
- Pages: 3281-3284
- First Published: 05 October 2020
Open Access
oa
Cardiovascular prognosis: a new role for ceramides and other cardiometabolites
- Pages: 3285-3287
- First Published: 11 October 2020
Original Research Articles
Open Access
oa
Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial
- Pages: 3288-3297
- First Published: 06 July 2020
Open Access
oa
Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis
- Pages: 3298-3309
- First Published: 22 December 2020
Open Access
oa
The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial
- Pages: 3310-3319
- First Published: 23 July 2020
Open Access
oa
Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure
- Pages: 3320-3328
- First Published: 13 August 2020
Open Access
oa
Long-term prognosis of patients treated by coronary sinus-based percutaneous annuloplasty: single centre experience
- Pages: 3329-3335
- First Published: 13 October 2020
Open Access
oa
Association of transcatheter direct mitral annuloplasty with acute anatomic, haemodynamic, and clinical outcomes in severe mitral valve regurgitation
- Pages: 3336-3344
- First Published: 11 September 2020
Open Access
oa
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes
- Pages: 3345-3354
- First Published: 23 October 2020
Open Access
oa
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF
- Pages: 3355-3364
- First Published: 19 October 2020
Open Access
oa
10 year trends in hospitalization rates due to heart failure and related in-hospital mortality in Poland (2010–2019)
- Pages: 3365-3373
- First Published: 22 October 2020
Open Access
oa
Lateral left ventricular lead position is superior to posterior position in long-term outcome of patients who underwent cardiac resynchronization therapy
- Pages: 3374-3382
- First Published: 22 October 2020
Open Access
oa
Individual patient data meta-analysis of the effects of the CARILLON® mitral contour system
- Pages: 3383-3391
- First Published: 22 December 2020
Open Access
oa
Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis
- Pages: 3392-3400
- First Published: 22 December 2020
Short Communications
Open Access
oa
Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME
- Pages: 3401-3407
- First Published: 11 September 2020
Open Access
oa
Distribution, infrastructure, and expertise of heart failure and cardio-oncology clinics in a developing network: temporal evolution and challenges during the coronavirus disease 2019 pandemic
- Pages: 3408-3413
- First Published: 07 October 2020
Editorials
Open Access
oa
Clinical problems of patients with cachexia due to chronic illness: a congress report
- Pages: 3414-3420
- First Published: 04 October 2020
Open Access
oa
ESC Heart Failure increases its impact factor
- Pages: 3421-3426
- First Published: 28 October 2020
Reviews
Open Access
oa
Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure: a meta-analysis
- Pages: 3427-3437
- First Published: 21 September 2020
Open Access
oa
Non-insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials
- Pages: 3438-3451
- First Published: 10 September 2020
Open Access
oa
Dying to know: prognosis communication in heart failure
- Pages: 3452-3463
- First Published: 24 September 2020
Open Access
oa
Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
- Pages: 3464-3472
- First Published: 16 September 2020
Open Access
oa
Foetal haemodynamic response to anaemia
- Pages: 3473-3482
- First Published: 10 September 2020
Open Access
oa
The overlooked chamber in coronavirus disease 2019
- Pages: 3483-3486
- First Published: 16 September 2020
Open Access
oa
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials
- Pages: 3487-3496
- First Published: 22 September 2020
Open Access
oa
The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
- Pages: 3497-3504
- First Published: 22 October 2020
Open Access
oa
Heart failure in the last year: progress and perspective
- Pages: 3505-3530
- First Published: 05 December 2020
Original Research Articles
Open Access
oa
Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
- Pages: 3531-3535
- First Published: 03 December 2020
Open Access
oa
Elevated plasma endothelin-1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
- Pages: 3536-3544
- First Published: 16 October 2020
Open Access
oa
Associations of region-specific visceral adiposity with subclinical atrial dysfunction and outcomes of heart failure
- Pages: 3545-3560
- First Published: 28 October 2020
Open Access
oa
Association of rs2070600 in advanced glycosylation end-product specific receptor with prognosis of heart failure
- Pages: 3561-3572
- First Published: 10 September 2020
Open Access
oa
The effect of transfusion of blood products on ventricular assist device support outcomes
- Pages: 3573-3581
- First Published: 14 October 2020
Open Access
oa
Cost-effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China
- Pages: 3582-3592
- First Published: 27 October 2020
Open Access
oa
Elevation of high-sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
- Pages: 3593-3600
- First Published: 12 October 2020
Open Access
oa
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology
- Pages: 3601-3609
- First Published: 17 September 2020
Open Access
oa
Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian meta-analysis
- Pages: 3610-3620
- First Published: 16 September 2020
Open Access
oa
Swollen heart in COVID-19 patients who progress to critical illness: a perspective from echo-cardiologists
- Pages: 3621-3632
- First Published: 25 September 2020
Open Access
oa
Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants
- Pages: 3633-3643
- First Published: 03 September 2020
Open Access
oa
Clinical characteristics and long-term outcomes of peripartum takotsubo cardiomyopathy and peripartum cardiomyopathy
- Pages: 3644-3652
- First Published: 08 September 2020
Open Access
oa
Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan
- Pages: 3653-3666
- First Published: 13 September 2020
Open Access
oa
Why is the clinical response to cardiac resynchronization better in LBBB patients?
- Pages: 3667-3675
- First Published: 18 September 2020
Open Access
oa
HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Association: The HERMES-HF Registry
- Pages: 3676-3684
- First Published: 16 September 2020
Open Access
oa
Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction
- Pages: 3685-3693
- First Published: 09 September 2020
Open Access
oa
Left ventricular dysfunction in atrial fibrillation and heart failure risk
- Pages: 3694-3706
- First Published: 15 September 2020
Open Access
oa
Metabolomic signatures of cardiac remodelling and heart failure risk in the community
- Pages: 3707-3715
- First Published: 10 September 2020
Open Access
oa
Multi-modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction ≤ 45%
- Pages: 3716-3725
- First Published: 23 October 2020
Open Access
oa
Subclinical cardiac dysfunction in obesity patients is linked to autonomic dysfunction: findings from the CARDIOBESE study
- Pages: 3726-3737
- First Published: 09 September 2020
Open Access
oa
Hepatocyte growth factor predicts failure of Fontan circulation
- Pages: 3738-3744
- First Published: 10 September 2020
Open Access
oa
Incidence of congestive heart failure in rheumatoid arthritis: a review of literature and meta-regression analysis
- Pages: 3745-3753
- First Published: 07 October 2020
Open Access
oa
A 3 year post-intervention follow-up on mortality in advanced heart failure (EVITA vitamin D supplementation trial)
- Pages: 3754-3761
- First Published: 11 September 2020
Open Access
oa
Improved 30 day heart failure rehospitalization prediction through the addition of device-measured parameters
- Pages: 3762-3771
- First Published: 13 September 2020
Open Access
oa
Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature
- Pages: 3772-3781
- First Published: 22 September 2020
Open Access
oa
Intensity level and cardiorespiratory responses to Baduanjin exercise in patients with chronic heart failure
- Pages: 3782-3791
- First Published: 09 September 2020
Open Access
oa
Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes
- Pages: 3792-3800
- First Published: 22 September 2020
Open Access
oa
Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
- Pages: 3801-3809
- First Published: 16 September 2020
Open Access
oa
Impact of right ventricular contractile reserve during low-load exercise on exercise intolerance in heart failure
- Pages: 3810-3820
- First Published: 13 September 2020
Open Access
oa
Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry
- Pages: 3821-3829
- First Published: 11 September 2020
Open Access
oa
Distinct clinical phenotypes of congestion in acute heart failure: characteristics, treatment response, and outcomes
- Pages: 3830-3840
- First Published: 10 September 2020
Open Access
oa
Efficacy and safety of sacubitril-valsartan in heart failure: a meta-analysis of randomized controlled trials
- Pages: 3841-3850
- First Published: 25 September 2020
Open Access
oa
A case-crossover study on the effect of short-term exposure to moderate levels of air pollution on the risk of heart failure
- Pages: 3851-3858
- First Published: 13 September 2020
Open Access
oa
Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fraction
- Pages: 3859-3870
- First Published: 13 September 2020
Open Access
oa
Epidemiology of heart failure: Study of Heart failure in the Australian Primary carE setting (SHAPE)
- Pages: 3871-3880
- First Published: 09 September 2020
Open Access
oa
Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial
- Pages: 3881-3890
- First Published: 21 September 2020
Open Access
oa
MitraClip implantation followed by insertion of a left ventricular assist device in patients with advanced heart failure
- Pages: 3891-3900
- First Published: 26 October 2020
Open Access
oa
Non-severe aortic regurgitation increases short-term mortality in acute heart failure with preserved ejection fraction
- Pages: 3901-3909
- First Published: 07 October 2020
Open Access
oa
Cost-effectiveness of empagliflozin in the UK in an EMPA-REG OUTCOME subgroup with type 2 diabetes and heart failure
- Pages: 3910-3918
- First Published: 10 September 2020
Open Access
oa
Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis
- Pages: 3919-3928
- First Published: 01 October 2020
Open Access
oa
Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure: a retrospective study
- Pages: 3929-3941
- First Published: 17 September 2020
Open Access
oa
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
- Pages: 3942-3949
- First Published: 13 September 2020
Open Access
oa
Impact of an extended audit on identifying heart failure patients in general practice: baseline results of the OSCAR-HF pilot study
- Pages: 3950-3961
- First Published: 24 September 2020
Open Access
oa
Major bleeding risk with non-vitamin K antagonist oral anticoagulant vs. aspirin in heart failure: network meta-analysis
- Pages: 3962-3970
- First Published: 13 September 2020
Open Access
oa
Age and shock severity predict mortality in cardiac intensive care unit patients with and without heart failure
- Pages: 3971-3982
- First Published: 10 September 2020
Open Access
oa
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
- Pages: 3983-3995
- First Published: 18 September 2020
Open Access
oa
Non-invasive telemonitoring improves outcomes in heart failure with reduced ejection fraction: a study in high-risk patients
- Pages: 3996-4004
- First Published: 19 September 2020
Open Access
oa
Clinical significance of spleen stiffness in patients with acute decompensated heart failure
- Pages: 4005-4014
- First Published: 13 September 2020
Open Access
oa
Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy
- Pages: 4015-4023
- First Published: 19 September 2020
Open Access
oa
Prognostic value of Mini Nutritional Assessment—Short Form with aortic valve stenosis following transcatheter aortic valve implantation
- Pages: 4024-4031
- First Published: 10 September 2020
Open Access
oa
Management of catheter ablation in arrhythmia patients during the coronavirus disease 2019 epidemic
- Pages: 4032-4039
- First Published: 17 September 2020
Open Access
oa
Reverse electromechanical modelling of diastolic dysfunction in spontaneous hypertensive rat after sacubitril/valsartan therapy
- Pages: 4040-4050
- First Published: 24 September 2020
Open Access
oa
The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
- Pages: 4051-4060
- First Published: 23 September 2020
Open Access
oa
Predictive value of heart failure with reduced versus preserved ejection fraction for outcome in pulmonary embolism
- Pages: 4061-4070
- First Published: 16 September 2020
Open Access
oa
Pulmonary artery pressures and outcomes after MitraClip
- Pages: 4071-4079
- First Published: 21 October 2020
Open Access
oa
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy
- Pages: 4080-4088
- First Published: 23 September 2020
Open Access
oa
Fibroblast-growth-factor-23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
- Pages: 4089-4099
- First Published: 16 September 2020
Open Access
oa
Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction
- Pages: 4100-4107
- First Published: 23 September 2020
Open Access
oa
Risk factors for myocardial injury in patients with coronavirus disease 2019 in China
- Pages: 4108-4117
- First Published: 02 October 2020
Open Access
oa
Prognostic value of D-dimer in acute myocardial infarction complicated by heart failure with preserved ejection fraction
- Pages: 4118-4125
- First Published: 26 October 2020
Open Access
oa
NT-pro-BNP in patients with left ventricular hypertrabeculation/non-compaction
- Pages: 4126-4133
- First Published: 23 September 2020
Open Access
oa
Clinical presentation and outcomes of peripartum cardiomyopathy in the Middle East: a cohort from seven Arab countries
- Pages: 4134-4138
- First Published: 23 September 2020
Open Access
oa
Prediction of chronic heart failure and chronic obstructive pulmonary disease in a general population: the Tromsø study
- Pages: 4139-4150
- First Published: 07 October 2020
Open Access
oa
Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease
- Pages: 4151-4158
- First Published: 13 October 2020
Open Access
oa
Overexpression of endothelial β3-adrenergic receptor induces diastolic dysfunction in rats
- Pages: 4159-4171
- First Published: 09 October 2020
Open Access
oa
Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
- Pages: 4172-4181
- First Published: 10 October 2020
Open Access
oa
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak
- Pages: 4182-4188
- First Published: 23 October 2020
Open Access
oa
Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study
- Pages: 4189-4197
- First Published: 22 October 2020
Open Access
oa
Influence of decompensated heart failure on cardiac acoustic biomarkers: impact on early readmissions
- Pages: 4198-4205
- First Published: 16 October 2020
Open Access
oa
Exploring correlates of improved depression symptoms and quality of life following tai chi exercise for patients with heart failure
- Pages: 4206-4212
- First Published: 09 October 2020
Open Access
oa
Optimal timing of echocardiography for heart failure inpatients in Japanese institutions: OPTIMAL Study
- Pages: 4213-4221
- First Published: 02 October 2020
Open Access
oa
Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial
- Pages: 4222-4230
- First Published: 11 October 2020
Open Access
oa
Endothelial dysfunction and the risk of heart failure in a community-based study: the Multi-Ethnic Study of Atherosclerosis
- Pages: 4231-4240
- First Published: 20 October 2020
Open Access
oa
Accuracy of Doppler blood pressure measurement in HeartMate 3 ventricular assist device patients
- Pages: 4241-4246
- First Published: 01 October 2020
Open Access
oa
Critical appraisal of the instantaneous end-diastolic pulmonary arterial wedge pressures
- Pages: 4247-4255
- First Published: 06 October 2020
Open Access
oa
Pathophysiological role of fatty acid-binding protein 4 in Asian patients with heart failure and preserved ejection fraction
- Pages: 4256-4266
- First Published: 02 November 2020
Open Access
oa
Nitrates in combination with hydralazine in cardiorenal syndrome: a randomized controlled proof-of-concept study
- Pages: 4267-4276
- First Published: 04 November 2020
Open Access
oa
Prediction of worsening heart failure events and all-cause mortality using an individualized risk stratification strategy
- Pages: 4277-4289
- First Published: 28 October 2020
Perspective
Open Access
oa
Being responsible for someone else: a shared duty for parents and heart failure specialists during the COVID-19 pandemic
- Pages: 4290-4292
- First Published: 07 October 2020
Case Reports
Open Access
oa
Safe application of extensive radiotherapy to a cardiac resynchronization device
- Pages: 4293-4296
- First Published: 11 October 2020
Open Access
oa
Takotsubo syndrome as a complication in a critically ill COVID-19 patient
- Pages: 4297-4300
- First Published: 04 September 2020
Open Access
oa
The De Winter-like electrocardiogram pattern in inferior and lateral leads associated with left circumflex coronary artery occlusion
- Pages: 4301-4304
- First Published: 14 September 2020
Open Access
oa
Isolated atrial amyloidosis suspected by electrophysiological voltage mapping and diagnosed by 99mTc-DPD scintigraphy
- Pages: 4305-4310
- First Published: 04 October 2020
Open Access
oa
Takotsubo syndrome in the same heart before and after heart transplantation
- Pages: 4311-4314
- First Published: 10 September 2020
Open Access
oa
Cardiac involvement with anti-mitochondrial antibody-positive myositis mimicking cardiac sarcoidosis
- Pages: 4315-4319
- First Published: 11 September 2020
Open Access
oa
Edge-to-edge tricuspid valve repair for severe tricuspid regurgitation 20 years after cardiac transplantation
- Pages: 4320-4325
- First Published: 18 September 2020
Open Access
oa
A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation
- Pages: 4326-4335
- First Published: 20 October 2020
Open Access
oa
A valuable cardiac magnetic resonance investigation after MINOCA/takotsubo Syndrome: a case report
- Pages: 4336-4342
- First Published: 23 September 2020
Open Access
oa
A rare case of severe right heart failure due to pulmonary artery lymphomatoid granulomatosis
- Pages: 4343-4347
- First Published: 10 September 2020
Open Access
oa
Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report
- Pages: 4348-4352
- First Published: 19 September 2020
Open Access
oa
De Winter syndrome as an emergency electrocardiogram sign of ST-elevation myocardial infarction: a case report
- Pages: 4353-4356
- First Published: 26 September 2020
Open Access
oa
Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failure
- Pages: 4357-4360
- First Published: 23 October 2020
Open Access
oa
A rise in left atrial pressure detected by the V-LAP™ system for patients with heart failure during the coronavirus disease 2019 pandemic
- Pages: 4361-4366
- First Published: 23 September 2020
Open Access
oa
Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment
- Pages: 4367-4370
- First Published: 15 October 2020
Open Access
oa
Delayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome
- Pages: 4371-4376
- First Published: 26 October 2020
Short Communications
Open Access
oa
Heart failure hospitalizations and costs in ICD/CRT-D recipients following replacement or upgrade: the DECODE registry
- Pages: 4377-4383
- First Published: 04 September 2020
Open Access
oa
A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy
- Pages: 4384-4389
- First Published: 01 September 2020
Open Access
oa
Impact of body mass index on surgical coronary revascularization for ischaemic heart failure: insights from STICHES
- Pages: 4390-4393
- First Published: 13 September 2020
Open Access
oa
Assessment of major mental disorders in a German peripartum cardiomyopathy cohort
- Pages: 4394-4398
- First Published: 10 September 2020
Open Access
oa
Relative contribution of risk factors/co-morbidities to heart failure pathogenesis: interaction with ejection fraction
- Pages: 4399-4403
- First Published: 19 September 2020
Open Access
oa
The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non-responders: a retrospective analysis
- Pages: 4404-4407
- First Published: 11 September 2020
Open Access
oa
Surface electrocardiographic characteristics in coronavirus disease 2019: repolarization abnormalities associated with cardiac involvement
- Pages: 4408-4415
- First Published: 08 September 2020
Open Access
oa
In-hospital mortality in heart failure in Germany during the Covid-19 pandemic
- Pages: 4416-4419
- First Published: 11 September 2020
Open Access
oa
Impact of lockdown on patients with congestive heart failure during the coronavirus disease 2019 pandemic
- Pages: 4420-4423
- First Published: 30 September 2020
Open Access
oa
Bedside chest ultrasound to distinguish heart failure from pneumonia-related dyspnoea in older COVID-19 patients
- Pages: 4424-4428
- First Published: 13 October 2020
Open Access
oa
Empagliflozin inhibits Na+/H+ exchanger activity in human atrial cardiomyocytes
- Pages: 4429-4437
- First Published: 18 September 2020
Open Access
oa
Regional protein expression changes within the left ventricle in a mouse model of dyssynchronous and resynchronized heart failure
- Pages: 4438-4442
- First Published: 27 October 2020
Open Access
oa
The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure
- Pages: 4443-4447
- First Published: 11 October 2020
Study Designs
Open Access
oa
Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)
- Pages: 4448-4457
- First Published: 17 September 2020
Open Access
oa
Mechanisms of Diuretic Resistance Study: design and rationale
- Pages: 4458-4464
- First Published: 06 September 2020
Open Access
oa
Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT-AHF trial
- Pages: 4465-4471
- First Published: 18 September 2020
Open Access
oa
How do SYMPtoms and management tasks in chronic heart failure imPACT a person's life (SYMPACT)? Protocol for a mixed-methods study
- Pages: 4472-4477
- First Published: 17 September 2020
Open Access
oa
Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trial
- Pages: 4478-4487
- First Published: 19 October 2020
Letters to the Editor
Open Access
oa
Sarcolipin acts as a bridge between diabetes and heart failure
- Page: 4488
- First Published: 10 September 2020
Open Access
oa
Crosstalk between the liver and heart: revisited for prevention and treatment
- Pages: 4489-4490
- First Published: 01 October 2020
Open Access
oa
Optimal echocardiographic ramp testing during left ventricular assist device supports
- Page: 4491
- First Published: 15 October 2020